Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

New research has highlighted the contribution of metabolic pathways and the gut–joint axis in osteoarthritis, pinpointing new ...

OKV-119 leverages Vivani's proprietary NanoPortal technology, which provides smooth and steady delivery of therapeutic molecules, including GLP-1 receptor agonists ... in feeding routines or ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, and Okava Pharmaceuticals, Inc.

FROM sulphur burps to diarrhoea, we’re all familiar with the brutal side effects of fat jabs – but have you heard of ‘Ozempic ...

Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...

The author supplements GLP-1 medication with vitamins and gummies to combat side effects and support overall health. Supplements mentioned include fiber, digestive enzymes, vitamins D and B12 ...

33,950 people played the daily Crossword recently. Can you solve it faster than others?33,950 people played the daily Crossword recently. Can you solve it faster than others?